Detalles de la búsqueda
1.
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis.
Br J Cancer
; 126(1): 34-41, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34671131
2.
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 162-174, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31806540
3.
A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin.
BJU Int
; 126(2): 292-299, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32336008
4.
Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study.
BMC Cancer
; 19(1): 60, 2019 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30642291
5.
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
N Engl J Med
; 373(18): 1697-708, 2015 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26510020
6.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Lancet
; 387(10024): 1163-77, 2016 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26719232
7.
Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11).
Prostate
; 76(16): 1519-1527, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27457964
8.
Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial.
Lancet Oncol
; 15(9): 975-85, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24974051
9.
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial.
Lancet Oncol
; 14(8): 760-8, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23742877
10.
Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer.
Invest New Drugs
; 31(4): 1001-7, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23329066
11.
Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre.
Cancer Med
; 12(5): 5255-5264, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36207803
12.
Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID).
J Clin Oncol
; 39(3): 190-201, 2021 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33326257
13.
Ten-Year Outcomes of Moderately Hypofractionated Salvage Postprostatectomy Radiation Therapy and External Validation of a Contemporary Multivariable Nomogram for Biochemical Failure.
Int J Radiat Oncol Biol Phys
; 107(2): 288-296, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31987961
14.
Genomics of lethal prostate cancer at diagnosis and castration resistance.
J Clin Invest
; 130(4): 1743-1751, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31874108
15.
Primary Mutational Landscape Linked with Pre-Docetaxel Lactate Dehydrogenase Levels Predicts Docetaxel Response in Metastatic Castrate-Resistant Prostate Cancer.
Eur Urol Focus
; 5(5): 831-841, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29699892
16.
Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.
Radiother Oncol
; 88(1): 102-7, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18453022
17.
Antitumour Activity and Safety of Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Abiraterone Acetate Plus Prednisone for ≥24 weeks in Europe.
Eur Urol
; 74(1): 37-45, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28844372
18.
Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer.
Int J Radiat Oncol Biol Phys
; 97(4): 732-739, 2017 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28244408
19.
Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.
J Clin Oncol
; 35(1): 48-55, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28034079
20.
Outcome analysis of 300 prostate cancer patients treated with neoadjuvant androgen deprivation and hypofractionated radiotherapy.
Int J Radiat Oncol Biol Phys
; 65(4): 982-9, 2006 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16750310